Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Autor: Griffiths, Christopher E M, Reich, Kristian, Lebwohl, Mark, van de Kerkhof, Peter, Paul, Carle, Menter, Alan, Cameron, Gregory S, Erickson, Janelle, Zhang, Lu, Secrest, Roberta J, Ball, Susan, Braun, Daniel K, Osuntokun, Olawale O, Heffernan, Michael P, Nickoloff, Brian J, Papp, Kim
Zdroj: In The Lancet 8-14 August 2015 386(9993):541-551
Databáze: ScienceDirect